S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.

Jerome SarrisJenifer MurphyCon StoughDavid MischoulonChad BousmanPatricia MacDonaldLaura AdamsSonia NazarethGeorgina OliverLachlan CribbKaren SavageRanjit MenonSuneel ChamoliMichael BerkChee H NgGerard J Byrne

Published in: Psychopharmacology (2019)

ANZCTR-Australian New Zealand Clinical Trials Registry; No.: ACTRN12613001299796; URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364900.

Keyphrases

clinical trial
study protocol
placebo controlled
double blind
open label
phase iii
phase ii
depressive symptoms
randomized controlled trial
combination therapy
sensitive detection
sleep quality
reduced graphene oxide
physical activity